0001209191-23-058912.txt : 20231218 0001209191-23-058912.hdr.sgml : 20231218 20231218091449 ACCESSION NUMBER: 0001209191-23-058912 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231215 FILED AS OF DATE: 20231218 DATE AS OF CHANGE: 20231218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chacko David M. CENTRAL INDEX KEY: 0001871801 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40602 FILM NUMBER: 231492406 MAIL ADDRESS: STREET 1: C/O ERASCA, INC. STREET 2: 10835 ROAD TO THE CURE, SUITE 140 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Erasca, Inc. CENTRAL INDEX KEY: 0001761918 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 831217027 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10835 ROAD TO THE CURE, SUITE 140 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 465-6511 MAIL ADDRESS: STREET 1: 10835 ROAD TO THE CURE, SUITE 140 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-12-15 0 0001761918 Erasca, Inc. ERAS 0001871801 Chacko David M. C/O ERASCA, INC. 3115 MERRYFIELD ROW, SUITE 300 SAN DIEGO CA 92121 0 1 0 0 CFO and CBO 0 Common Stock 2023-12-15 4 J 0 7478 1.5895 A 246726 D Shares purchased under the issuer's 2021 Employee Stock Purchase Plan. The purchase price was calculated in accordance with the issuer's 2021 Employee Stock Purchase Plan. /s/ Ebun Garner, attorney-in-fact 2023-12-17